Effect of orlistat in overweight or obese patients with treated but inadequately controlled diastolic hypertension

被引：0
|
作者：
Bakris, G
Calhoun, D
Egan, B
Hellmann, C
Kingma, I
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[2] Univ Alabama, Birmingham, AL USA
[3] Med Univ S Carolina, Charleston, SC 29425 USA
[4] Roche Labs Inc, Nutley, NJ USA
来源：
OBESITY RESEARCH | 2001年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：188S / 188S
页数：1
相关论文
共 50 条
  • [41] Effect of orlistat-induced weight loss on blood pressure and heart rate in obese patients with hypertension
    Sharma, AM
    Golay, A
    JOURNAL OF HYPERTENSION, 2002, 20 (09) : 1873 - 1878
  • [42] Orlistat treatment significantly improves blood pressure, glycaemic control and lipid profile in obese/overweight patients with type 2 diabetes and hypertension
    Broom, Iain
    Guy-Grand, Bernard
    Hill, Julie
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S152 - S152
  • [43] Effect of orlistat during individualized comprehensive life-style intervention on visceral fat in overweight or obese PCOS patients
    Min, Min
    Ruan, Xiangyan
    Wang, Husheng
    Cheng, Jiaojiao
    Luo, Suiyu
    Xu, Zhongting
    Li, Meng
    Mueck, Alfred Otto
    GYNECOLOGICAL ENDOCRINOLOGY, 2022, 38 (08) : 676 - 680
  • [44] Effect of orlistat on the total ghrelin and leptin levels in obese patients
    Ozkan, Y.
    Aydin, S.
    Donder, E.
    Koca, S. S.
    Aydin, Suna
    Ozkan, B.
    Sahin, I.
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2009, 65 (03) : 215 - 223
  • [45] Effect of orlistat on the total ghrelin and leptin levels in obese patients
    Y. Ozkan
    S. Aydin
    E. Donder
    S S. Koca
    Suna Aydin
    B. Ozkan
    I. Sahin
    Journal of Physiology and Biochemistry, 2009, 65 : 215 - 223
  • [46] The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy
    Tai, He
    Wang, Ming-Yue
    Zhao, Yue-Ping
    Li, Ling-Bing
    Dong, Qian-Yan
    Liu, Xin-Guang
    Kuang, Jin-Song
    MEDICINE, 2016, 95 (33)
  • [47] Effect of rimonabant on systolic and diastolic blood pressure in overweight/obese patients with/without co-morbidities
    Van Gaal, L.
    Scheen, A.
    Després, J. -P.
    Pi-Sunyer, F. X.
    Rissanen, A.
    Golay, A.
    JOURNAL OF HYPERTENSION, 2006, 24 : S80 - S80
  • [48] Weight management with orlistat is effective in weight loss and diastolic blood pressure reduction in overweight/obese hypertensives, uncontrolled on medication.
    Calhoun, DA
    Egan, BM
    Li, G
    Kingma, I
    CIRCULATION, 2000, 102 (18) : 416 - 416
  • [49] Latin-American multicentric study with orlistat in overweight or obese patients with type 2 diabetes
    Halpern, A
    DIABETOLOGIA, 2001, 44 : A232 - A232
  • [50] The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome
    Panidis, Dimitrios
    Tziomalos, Konstantinos
    Papadakis, Efstathios
    Chatzis, Panagiotis
    Kandaraki, Eleni A.
    Tsourdi, Elena A.
    Katsikis, Ilias
    CLINICAL ENDOCRINOLOGY, 2014, 80 (03) : 432 - 438
12345